NCT06260332

Brief Summary

This clinical trial tests whether increased activity throughout the day can improve the chronic pain and associated symptoms that breast cancer survivors may experience after surgery. Staying active is a key factor of one's physical, mental, and social health and well-being. Moving more could also reduce pain and associated stress, anxiety, or depression. Using a fitness tracker may help patients to move around more, whether or not they choose to exercise. Information gathered from this study may help researchers learn how the use of a Fitbit tracker with health coaching may improve physical activity and reduce pain in young, Hispanic breast cancer survivors.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for not_applicable breast-cancer

Timeline
8mo left

Started Oct 2023

Typical duration for not_applicable breast-cancer

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress80%
Oct 2023Dec 2026

Study Start

First participant enrolled

October 20, 2023

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

January 23, 2024

Completed
23 days until next milestone

First Posted

Study publicly available on registry

February 15, 2024

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 27, 2024

Completed
2.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Expected
Last Updated

October 23, 2025

Status Verified

October 1, 2025

Enrollment Period

10 months

First QC Date

January 23, 2024

Last Update Submit

October 21, 2025

Conditions

Outcome Measures

Primary Outcomes (4)

  • Recruitment rate (Feasibility)

    This study will be considered feasible with the recruitment of 25 breast cancer patients.

    Up to 1 year

  • Retention rate (Feasibility)

    This study will be considered feasible if 80% of patients complete all pre and post assessments.

    Up to 12 weeks

  • Adherence rate (Feasibility)

    This study will be considered feasible if participants complete at least 4 of 5 health coaching sessions (80%).

    Up to 12 weeks

  • Incidence of adverse events

    Safety will be tracked by the study team.

    Up to 12 weeks

Secondary Outcomes (3)

  • Change in chronic post-surgical pain

    At 13 weeks

  • Change in physical activity

    At 13 weeks

  • Change in health-related quality of life (hrQOL)

    At 13 weeks

Study Arms (1)

Supportive Care (Fitbit)

EXPERIMENTAL

Patients wear a Fitbit and use the Fitbit application to monitor their physical activity daily in weeks 2-12 with the goal of increasing their number of steps per day and their number of active hours per day. Starting at week 2, patients also receive educational materials and attend 6 calls over 20-60 minutes each with their health coach in weeks 2, 3, 5, 7, 9, and 11.

Behavioral: Supportive Care (Fitbit)

Interventions

Wear Fitbit, Use Fitbit application, Receive educational materials, attend coaching calls, Ancillary studies

Also known as: Medical Device Usage and Evaluation, Internet-Based Intervention, Educational Activity, Counseling, Survey Administration
Supportive Care (Fitbit)

Eligibility Criteria

Age18 Years - 60 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsFemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Women who have completed surgery for invasive breast cancer \>= 6 months prior to enrollment
  • Any breast surgery (lumpectomy or mastectomy)
  • Baseline low to moderate activity level (exercise less than 120 minutes a week)
  • PBSPS defined as pain in the area of breast surgery of at least moderate intensity (\>= 4 on a scale of 1-10), located in the ipsilateral beast/chest wall, axilla or arm, lasting at least 6 months, and occurring at least 50% of the time
  • Self-identified as Hispanic/Latinx
  • Age, \>= 18 and =\< 60 years
  • Endocrine therapy and ovarian suppression is allowed

You may not qualify if:

  • Metastatic or locally recurrent disease with no option for curative intent treatment
  • Meeting or exceeding physical activity guidelines (\> 150 minutes per week of moderate-intensity exercise)
  • Unable to speak, read, and understand English or Spanish
  • Severe impairments (in seeing or hearing) or pre-existing medical limitations for engaging in daily physical activity. This is defined as the ability to walk 3 blocks without stopping to rest and without using an assistive device
  • Unwilling to use a study provided smartphone (if do not already own one) and wear activity trackers/monitors
  • Adults not able to consent are excluded from participation
  • Based on the age criteria (18 years and older), individuals who are not yet adults (infants, children, teenagers) may not participate in this study due to the same age criteria above
  • Pregnant women
  • Prisoners may not participate in this study as this is a study of free-living individuals

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of New Mexico Comprehensive Cancer Center

Albuquerque, New Mexico, 87106, United States

Location

Related Links

MeSH Terms

Conditions

Breast Neoplasms

Interventions

Palliative CareCounseling

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

Patient CareTherapeuticsHealth ServicesHealth Care Facilities Workforce and ServicesMental Health ServicesBehavioral Disciplines and ActivitiesCommunity Health Services

Study Officials

  • Jacklyn M Nemunaitis, MD

    New Mexico Cancer Research Alliance

    PRINCIPAL INVESTIGATOR
  • Cindy K Blair, Ph.D.

    New Mexico Cancer Research Alliance

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 23, 2024

First Posted

February 15, 2024

Study Start

October 20, 2023

Primary Completion

August 27, 2024

Study Completion (Estimated)

December 31, 2026

Last Updated

October 23, 2025

Record last verified: 2025-10

Data Sharing

IPD Sharing
Will not share

Locations